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Whole-genome sequencing - a transformation in 
bacterial epidemiology
The application of whole-genome sequencing affords the 
opportunity to generate bacterial nucleic acid sequence 
data of extraordinary resolution, making it possible to 
identify single base changes within entire genomes. The 
development of second (and third) generation sequencing 
technology has largely been driven by the desire to assess 
human genetic variation rapidly by mapping genome-
wide single-nucleotide polymorphisms (SNPs). Several 
recent studies have applied similar analyses at the whole-
genome level to the much smaller genomes of bacteria, 
providing data of very fine-scale resolution and enabling 
the evolutionary history of multiple strains within a 
clonal lineage to be determined [1-8]. Not surprisingly, 
these studies have focused on bacterial pathogens 
because of their importance in disease.
Distinguishing individual bacterial lineages within a 
species, initially by phenotypic and subsequently by 
genotypic typing techniques, has been the cornerstone of 
infectious disease epidemiology, allowing the identifi ca-
tion and tracking of the organisms responsible for 
infection and disease. On a wider scale, molecular typing 
is central to determining the population structure and 
under standing the evolution of bacterial pathogens. To 
date, sequence-based typing approaches, such as multi-
locus sequence typing (MLST), have relied on variation 
within a few genes [9]. Although such techniques are 
highly informative, they have limited resolution when 
applied to closely related isolates. Thus, they are often 
unsuitable for identifying fine-grained evolutionary 
events or for distinguishing clonal strains within a recent 
epidemic [10]. This situation has now been improved by 
the application of next-generation sequencing to bacterial 
collections of known origin and provenance. We review 
recent examples in which such studies have informed our 
understanding of the epidemiology and evolution of 
bacterial pathogens.
Phylohistory and phylogeography: from the ‘Black 
Death’ to hospital-acquired infections
Studies of the phylogeny of a species or of a clonal lineage 
within a species are highly dependent on the quantity and 
diversity of isolates sampled in the study. Recently, it has 
become possible to fully sequence significant numbers of 
isolates in strain collections, revealing new information on 
their temporal and spatial transmission dynamics.
Yersinia pestis
As a recent pathogen, the plague bacillus Yersinia pestis 
is genetically uniform. Thus, it is relatively simple to trace 
the source and to determine the global phylogenetic 
diversity of this bacillus using whole-genome SNP 
analysis. Such an analysis of a global collection of strains 
showed that Y. pestis originated in or around China, 
confirming the ‘out of China’ hypothesis whereby initial 
transmission was along East-West trade routes such as 
the Silk Road. Multiple radiations from China to Europe, 
Africa and Southeast Asia can be traced to country-
specific SNP lineages [4]. Further fine analysis uncovered 
the phylogeography of Y. pestis in North America, where 
it radiated from a single introduction, and in Madagascar, 
where again it radiated from a single introduction. These 
and other radiations largely matched historical accounts 
of the disease and known trading routes [4] (Figure 1).
The causative agent of the ‘Black Death’ has been a 
matter of considerable debate [11]. Disease symptoms 
such as inflamed buboes led to the assumption that the 
‘Black Death’ was a typical Y. pestis infection, but other 
etiologic agents, including hemorrhagic viruses, have been 
proposed on the basis of clinical and epidemio logical 
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information. The SNP analysis used to trace the 
phylohistory of Y. pestis [4] is a development of an earlier 
SNP analysis [12] that has already been used to provide 
information on ancient bacterial DNA. Specifically, it had 
been used to analyze DNA extracted from human dental 
pulp taken from medieval mass graves in several 
European locations [11]. The analysis made it possible 
not only to amplify Y. pestis DNA taken from the victims 
but also to place these bacterial DNA sequences in the 
correct historical context through phylogenetic analysis. 
The results imply that at least two distinct ancient clones 
of Y. pestis were responsible for the ‘Black Death’, at least 
one of which appears to be extinct. These findings 
definitively show that Y. pestis was the causative agent of 
the ‘Black Death’.
Vibrio cholerae
Cholera, caused by Vibrio cholerae, is another ancient 
scourge that has recently been studied by rapid genome 
sequencing. The current (seventh) cholera pandemic, 
recently manifest in Zimbabwe, Pakistan and Haiti, is 
caused by the El Tor biotype of serogroup O1 (El Tor 
O1) [13,14]. Two clinical V. cholerae isolates from the 
current outbreak in Haiti were fully sequenced in less 
than 24  hours using third-generation sequencing with 
the PacBio RS sequencing system [15]. Third-generation 
single-molecule real-time sequencing with this system 
involves direct observation of the DNA polymerase 
while it synthesizes a strand of DNA. It has advantages 
over second-generation sequencing in terms of increased 
read length and speed. Whole-genome sequence 
comparisons with reference strains confirmed that the 
Haitian cholera epidemic is clonal and El Tor O1, and 
suggested that the V. cholerae strain was introduced into 
Haiti by human activity from a distant geographic 
source [15]. Although this was a limited study, the data 
suggest that a South Asian variant of V. cholerae El Tor 
O1 has recently been accidentally introduced into Haiti. 
Figure 1. Phyogeography of Yersinia pestis, identifying transmission routes out of China and single introductions into the US and 
Madagascar [4]. The figure represents a minimal spanning tree describing the relationship of the Y. pestis isolates. Colored circles represent 
genotypes, colored according to geographical location, and the size of the circle indicates the number of strains with that genotype. Letters within 
the circles indicate node designations. Grey text on lines between nodes shows the numbers of SNPs separating each node, except that one or 
two SNPs are indicated by thick and thin black lines, respectively. It is clear that the different genotypes show a strong geographical signal, and the 
relationships between them therefore suggest geographical transmission routes.
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This theory is consistent with the epidemiological 
evidence [16].
Clostridium difficile
Genetic epidemiological studies are likely to prove par-
ticu larly useful for tracing the routes of transmission and 
sources of infection for hospital-acquired infections. 
Whole-genome sequencing has been used to explore the 
phylogeny, horizontal gene transfer, recombination, and 
micro- and macroevolution of the major hospital-acquired 
pathogen Clostridium difficile [5,17,18]. This infection 
produces a wide range of symptoms from mild diarrhea 
to life-threatening pseudomembranous colitis, and charac-
teristically occurs after treatment with broad-spectrum 
antibiotics. The hospital environment in which there are 
people undergoing antibiotic treatment pro vides a 
discrete ecosystem in which C. difficile persists and select 
virulent clones thrive. Consequently, C. difficile is the 
most frequent cause of nosocomial diarrhea worldwide 
[19,20].
Phylogenetic analysis demonstrates that C. difficile is a 
genetically diverse species, with estimates of the date of 
the most recent common ancestor (MRCA) varying from 
1.1 to 85 million years before present. By contrast, the 
disease-causing isolates (PCR-ribotypes 017s, 027s, and 
078s) have arisen from multiple lineages over very short 
evolutionary timescales. This suggests that virulence has 
evolved independently in several highly epidemic 
lineages [5], and contradicts the notion that a single 
lineage evolved to become pathogenic. For example, the 
MRCA of the very recently emerged PCR-ribotype 027 
hypervirulent lineage was confirmed at approximately 
30 years ago, consistent with the dates of the transconti-
nental spread of C. difficile [5,21,22]. This has implica-
tions for the emergence of C. difficile as a human patho-
gen. Although C. difficile appears to be an ancient species, 
it was recognized as a pathogen only 30 years ago, 
indicating that genetic modifications, changes in inter-
actions between host and pathogen, and factors such as 
human activity, hospital design and antibiotic use might 
have contributed to the recent emergence of C. difficile as 
a major pathogen.
Methicillin-resistant Staphylococcus aureus
The first large-scale whole-genome analysis of a clonal 
lineage within a species was undertaken for an epidemic 
sequence type (ST239) of the notorious hospital patho-
gen methicillin-resistant Staphylococcus aureus (MRSA). 
The collection of 63 geographically diverse ST239 repre-
sentatives over four decades revealed clear evidence of 
both geographical grouping and intercontinental trans-
mission over time [6]. The resolution of the whole-
genome SNP analysis was so fine that it revealed the 
microevolution of MRSA within a Thai hospital over a 
7-month period. It was even able to determine when new 
strains were introduced from the community, or when 
they were acquired by person-to-person transmission 
within the hospital environment. Thus, very high-reso-
lution phylogenetic analyses enable detailed epidemio-
logical reconstructions at the global (that is, spread by 
modern transport) and local (that is, within hospital) 
levels, suggesting that such analyses are likely to be 
clinically applicable in the near future.
Streptococcus pneumonia
A similar whole-genome analysis of 240 Streptococcus 
pneumoniae isolates of the antibiotic-resistant PMEN1 
clonal lineage (which is often serotype 23F) tracked the 
phylogeny of this recombinogenic lineage by SNP 
analysis, after accounting for the confounding effect of 
extensive recombination [3]. The phylogeny of the 
PMEN1 clone confirms that it arose around 40 years ago. 
Analysis of genetic markers, together with the prove-
nance of the strains, suggests that the introduction of the 
heptavalent PCV7 glycoconjugate vaccine in the US 
(designed against 7 of the 90 pneumococcal serotypes, 
including 23F) effectively led to the depletion of the 
resident 23F population. However, this selective pressure 
opened the niche to non-vaccine serotypes such as 19A. 
These studies strongly suggest that although some of 
these non-vaccine isolates were from the same lineage as 
the 23F serotype, they had acquired a new non-vaccine 
capsule type before the introduction of the vaccine. This 
demonstrates that, despite the remarkable adaptability of 
recombinogenic bacteria such as the pneumococcus, 
strong vaccine pressure can remove the population that 
expresses vaccine-type capsules before it can switch its 
capsule genes. The emergence of vaccine-escape strains 
such as the 19A serotype thus has important implications 
for the introduction of partial species coverage vaccines. 
Such interventions require vigilance and the genomic 
surveillance of all bacterial clones. Overall, this study 
shows the surprisingly rapid evolution of a recombino-
genic bacterial pathogen that can be linked to clinical 
inter ventions such as antibiotic usage and the intro-
duction of vaccines.
Group A Streptococcus
The Group A Streptococcus (GAS) is a Gram-positive, 
human pathogen responsible for diseases ranging from 
pharyngitis to life-threatening invasive disease. It has 
been dubbed the ‘flesh eating bug’ by the popular media. 
The whole-genome analysis of 344 serotype M3 GAS 
strains from three epidemics (over a 16-year period) in 
Ontario, Canada, was undertaken using a combination of 
sequencing and SNP analysis [7]. This revealed a 
relationship among the 344 invasive strains responsible 
for the three epidemics, which comprised a dynamic 
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mixture of distinct clonally related complexes (Figure 2). 
The resulting evolutionary genetic framework facilitated 
an assessment of the phylogeographic features of these 
epidemics. The data confirm that each epidemic is 
composed of strains that are genetically distinct from 
those involved in the preceding epidemic, rather than re-
emerging genetically identical organisms. Further investi-
ga tions should provide an enhanced understanding of the 
genomic relationships between the serotype M3 strains 
that cause pharyngitis and invasive infections, thereby 
potentially forewarning of lethal GAS infections.
A novel aspect of this study was the use of information 
generated from whole-genome analysis to select repre-
sentative strains for comparative transcriptome and mass 
spectroscopy SNP analyses [7,23]. A comparative study of 
transcriptome expression in a subset of strains revealed 
that closely related strains, which are differentiated by 
apparently modest genetic changes, can have significantly 
divergent transcriptomes. Therefore, subtle genetic changes 
could have more significant phenotypic conse quences 
than previously appreciated.
Deriving evolutionary information from mutation 
rates and phylogenetic analysis
One advantage of whole-genome SNP analysis is that it 
could be used to identify non-synonymous mutations 
that are more likely to be influenced by evolutionary 
selective pressure than synonymous mutations or muta-
tions in intergenic DNA. The identification of genes that 
have undergone non-synonymous mutations should 
provide clues to the evolutionary pressures experienced 
over time by a bacterial species or clonal lineages within 
a species. Traditionally, the selective forces acting on a 
bacterial genome were investigated by calculating the 
ratio of non-synonymous to synonymous substitutions 
(dN/dS) for a given species comparison [24]. A ratio 
significantly less than 1 suggests strong purifying or 
stabilizing selection, whereas a ratio close to 1 suggests a 
neutral selection pressure, and a ratio greater than 1 
indicates diversifying selection. For very closely related 
genomes (for example, those within clonal lineages), 
however, dN/dS can be close to 1 simply because there 
has been insufficient time for selection to act [25]. This, 
combined with the very small number of mutations in 
individual genes within these lineages, actually makes the 
identification of genes under selection very difficult. 
Nevertheless, the increasing number of strains within 
bacterial collections that are currently being sequenced 
does allow some inferences relating to genetic selection.
The whole-genome sequencing of 19 isolates of 
Salmonella enterica serovar Typhi (S. Typhi), a human-
restricted bacterial pathogen that causes typhoid fever, 
confirmed the very limited genetic variation within this 
species. The mean dN/dS of each isolate in comparison 
with the last common ancestor was approximately 0.66, 
suggesting that there has been a weak trend towards 
stabilizing selection since the occurrence of the MRCA) 
of S. Typhi [8]. Detailed analysis of the SNPs showed little 
evidence of diversifying selection, antigenic variation or 
recombination between isolates. Only 38% of genes had 
any sequence variation at all, and the occurrence of 
variants in almost all of these genes appeared to match 
random expectation. Nevertheless, evidence for selection 
could be found by looking for SNPs that occurred 
independently on different branches of the tree (that is, 
for homoplasy, or convergent evolution). Examples of 
Figure 2. Changes in Group A Streptococcus subclones within three epidemics over time. The frequency distribution of all strains in the three 
epidemics is shown in grey, with three peaks of infection centered around 1995, 2000, and 2005. Ten major subclones (SC1 to SC10) were identified 
among the 344 strains collected between 1992 and 2007. The widths of the colored SC symbols show the temporal distribution of the SCs, and the 
heights are proportional to the annual abundance. Arrows between SCs indicate estimated relationships and give differences in the loci assessed 
[7]. It can be seen that although there is some carry-over of lineages between epidemic peaks, new lineages arise and contribute to each epidemic.
Parkhill and Wren Genome Biology 2011, 12:230 
http://genomebiology.com/2011/12/10/230
Page 4 of 7
such non-synonymous mutations include those in gyrA 
that are responsible for resistance to quinolone-based 
antibiotics. No genes besides gyrA contained multiple 
homoplasic SNPs, and very few genes had an excess of 
non-synonymous SNPs, showing that unlike the strong 
adaptive selection for mutations conferring antibiotic 
resistance, there is little evidence for selective pressure 
for antigenic variation driven by immune selection. This 
is consistent with the previous assertion that most of the 
variants in the Typhi genome accumulate by genetic drift 
[26]. The adaptive mutations evident in the gyrA gene 
highlight the strong selective pressure on the S. Typhi 
genome associated with antibiotic use in the human 
population. This is not particularly surprising as the 
fitness advantage associated with increased antibiotic 
resistance is very strong. The paucity of similar evidence 
for other adaptive mutations suggests that S. Typhi is 
under relatively little selective pressure from its human 
host, consistent with its long-term carriage within a 
protected niche, the gall-bladder.
The technique of identifying genes with a significant 
excess of SNPs has also been used in the Group A 
Streptococcus data set [7]: just under 5% of the variable 
genes were found to have a statistical excess of variants. 
These included several surface proteins and virulence 
factors, along with a regulator, ropB, that controls 
multiple virulence genes, indicating that selection by the 
host is a significant factor in the recent evolution of this 
organism.
For C. difficile, dN/dS was calculated for different 
clonal lineages. The data from deeply diverging lineages 
provided evidence of strong purifying selection. For 
example, the average dN/dS between the divergent 
lineage 078 and the other strains tested is ≈0.08 [5]. By 
contrast, for recently diverged lineages, such as the 027 
ribotype, dN/dS is very close to 1, consistent with the 
delayed action of purifying selection [25] and again 
making it difficult to identify genes that are under 
selection. The extensive full-genome data in this study 
did, however, permit the identification of genes that had 
significantly increased rates of non-synonymous 
nucleotide polymorphism, thereby providing clues about 
the operation of selective forces in the host.
A similar approach for identifying genes that are under 
selection (that is, searching for homoplasic SNPs within 
the background of random SNPs that delineate the tree) 
was used in the MRSA ST239 study. Again, there was a 
relatively small number of homoplasic SNPs (less than 
1%) in the core genome, but around 30% of these could 
be directly linked to the evolution of resistance to 
antibiotics currently in use (for example, quinolones, 
rifampicin, mupirocin and trimethoprim). These findings 
confirm that antibiotic use is a major driving force in the 
evolution of MRSA, and that this technique can detect 
recent selection [6]. Nevertheless, the majority of homo-
plasies were found in genes for which no reason for 
selective pressure could be clearly identified. Understand-
ing how and why these mutations are selected could 
provide novel information on the emergence of multi-
drug-resistant clonal lineages.
The ability to distinguish vertically acquired substitu-
tions from horizontally acquired sequences is crucial to 
reconstructing phylogenies for recombinogenic organisms. 
This was recently attempted for the S. pneumoniae data 
set, in which 88% of the variants were estimated to have 
been introduced by recombination. Despite this, the 
relative likelihood that a polymorphism was introduced 
through recombination rather than by point mutation 
(r/m ratio) was estimated to be 7.2, less than the 
previously calculated value of approximately 66 from 
MLST data [3]. By removing recombination events from 
the phylogeny, the number of homoplasic sites was 
reduced by 97%, and the apparent rate of SNP accumu-
lation was much more consistent within the tree, thus 
considerably strengthening the core phylogeny and the 
inferences that could be made from it.
The large majority of the SNPs identified in these 
studies of recent clones are effectively neutral over these 
timescales, and thus they can be used to give a good 
estimate of the current mutation rate. Curiously, this 
estimate for S. pneumoniae and S. aureus is roughly 1,000 
times greater than that estimated from the synonymous 
substitution rate between deeper bacterial lineages (such 
as Escherichia coli and Salmonella) [27]. This apparent 
discrepancy can be reconciled by the fact that synony-
mous sites, commonly assumed to be neutral, are in fact 
under selection over longer time periods because of 
pressures such as G+C content and codon usage.
Limitations and future perspectives
Advances in sequencing technologies have enabled the 
whole-genome phylogenies of multiple clonal isolates to 
be determined readily, but as with all microbial 
epidemiological investigations, the size and composition 
of the strain collection investigated is crucial for subse-
quent biological interpretations. This is particularly 
relevant for bacterial pathogens that reside in multiple 
niches: isolates are frequently collected only from 
patients. This might bias the data sets and provide an in-
complete picture of the true diversity of a bacterial 
species, which might have alternative niches and reser-
voirs to humans. The lack of representation of the true 
diversity results in gaps in our evolutionary know ledge of 
a given pathogen. For example, there appears to be huge 
evolutionary distances between current epidemic clonal 
lineages of C. difficile. Nevertheless, because so much 
data can now be derived from bacterial isolates, it is now 
more important than ever to engage appropriately with 
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clinicians and strain collectors and to acquire accurate 
strain provenance.
Current sequencing approaches are limited for more 
divergent bacterial pathogens. As more representatives of 
clonal lineages within a bacterial species are sequenced 
and as sequencing technology continues to improve, 
however, more diverse and panmictic bacterial popula-
tions will be sequenced. This might be particularly reveal-
ing for organisms such as Helicobacter pylori, which is 
resident in the stomachs of half of the human population. 
MLST analysis of multiple H. pylori strains has been used 
to re-construct and confirm human population expansion 
and migration in Africa, Europe and the Pacific [28]. The 
higher resolution of whole-genome sequencing promises 
significant progress towards tracing human pre-history.
Notwithstanding these limitations, molecular epidemi-
o logy has clearly come of age for clonal bacterial 
pathogens. The major advantage of whole-genome 
sequenc ing is its power to discriminate between isolates, 
enabling the generation of robust phylogenies. This 
provides greater confidence in identifying the origins of 
infections and the routes of transmission, as demon-
strated by the monitoring of patient-to-patient transfer of 
bacteria within a hospital [6,29] or within a community 
[2]. Such finely tuned transmission tracking will be vital 
in determining whether factors such as patient-to-patient 
transmission are important in the spread of the disease. 
In the future, this may facilitate the practice of proactive 
infectious disease surveillance to truncate or avert 
epidemics.
In contrast to most typing methods, whole-genome 
sequencing also facilitates the direct identification of 
gene losses and gene gains that can play a role in the 
evolution of a bacterial species or clonal lineage within a 
species. Such information has frequently identified the 
emergence of antibiotic resistance within populations, 
which is often associated with increased antibiotic usage. 
Nevertheless, other more subtle selective forces are also 
likely to be important in the emergence of bacterial 
pathogens, and our current knowledge in this area is 
lacking. High-throughput sequencing holds the promise 
of mapping more subtle associations between phenotype 
and genotype [30,31]. The next few years will see an 
increase in the biological interpretation of such muta-
tions using high-throughput in vitro assays and the 
selected testing of representative isolates in animal 
infection studies. This should further our understanding 
of the host, ecological, environmental and human forces 
that are important in the evolution of bacterial pathogens 
and enable further appropriate interventions to be made. 
Another area in which we lack knowledge is how and 
why some bacterial lineages appear to diminish, or even 
become extinct. For example, the S. pneumoniae lineage 
BM4200 is a multidrug-resistant serotype 23F isolate 
from 1978, but despite its similarity to the PMEN1 
isolates, it is now seldom found [32]. As genome 
sequencing, SNP detection and geospatial information 
become more accessible, these methods will continue to 
transform the way molecular epidemiology is used to 
study populations of bacterial pathogens.
Concluding remarks
We are now in a new era of high-throughput, sequence-
based microbiology that will have important implications 
for health service providers working with infectious 
diseases. Rather than merely identifying a particular 
bacterium by culture, whole-genome sequencing will 
provide a better understanding of its origin and disease 
potential. As global positioning systems become more 
accessible and merge with molecular epidemiology, more 
accurate geospatial information on the origins of strains 
and outbreaks will become available. Just as the DNA 
fingerprinting of human microsatellites changed our lives 
through diverse applications from paternity testing to 
crime screen investigations, next-generation sequencing 
means that molecular epidemiology is set to be 
revolutionized for clonal bacterial pathogens. The next 
few years promise a voyage of discovery in terms of the 
attribution of sources and transmission tracking of 
bacteria, the understanding of how and why epidemic 
clones emerge or disappear, and ultimately the manage-
ment and treatment of infectious diseases.
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